Noradrenergic modulation of the discriminative-stimulus effects of methamphetamine in rats

Psychopharmacology

Volumn 143, Issue 3, 1999, Pages 293-301

  Munzar, Patrik ^a   Goldberg, Steven R ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Clonidine; Desipramine; Drug discrimination; Isoproterenol; Methamphetamine; Methoxamine; Nisoxetine; Norepinephrine; Prazosin; Propranolo l; Rat; Yohimbine

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; AMPHETAMINE; DESIPRAMINE; ISOPRENALINE; METHAMPHETAMINE; NISOXETINE; PRAZOSIN; PROPANOL; SODIUM CHLORIDE; YOHIMBINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DISCRIMINATION; DRUG EFFECT; DRUG MECHANISM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEUROCHEMISTRY; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RAT; RECEPTOR INTRINSIC ACTIVITY; REGULATORY MECHANISM;

ADRENERGIC AGENTS; ANIMALS; DISCRIMINATION LEARNING; MALE; METHAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, ALPHA-2;

EID: 0032963205     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050950     Document Type: Article

References (41)

1. Callahan PM, Cunningham KA (1998) Noradrenergic involvement in the discriminative stimulus effects of cocaine in rats. In: Problems of drug dependence 1997: Proceedings of the 59th Annual Scientific Meeting. NIDA Research Monograph Series 178:216
2. Colpaert FC, Niemegeers CJE, Janssen PAJ (1979) Discriminative stimulus properties of cocaine: neuropharmacological characteristics as derived from stimulus generalization experiments. Pharmacol Biochem Behav 10:535-546
3. Cunningham KA, Callahan PM (1991) Monoamine reuptake inhibitors enhance the discriminative state induced by cocaine in the rat. Psychopharmacology 104:177-180
4. Daws LC, Toney GM, Gerhardt GA, Frazer A (1998) In vivo chronoamperometric measures of extracellular serotonin clearance in rat dorsal hippocampus: contribution of serotonin and norepinephrine transporters. J Pharmacol Exp Ther 286: 967-976
5. D'Mello GD (1982) Comparison of the discriminative stimulus properties of clonidine and amphetamine in rats. Neuropharmacology 21:763-769
6. Florin SM, Kuczenski R, Segal DS (1994) Regional extracellular norepinephrine responses to amphetamine and cocaine and effects of clonidine pretreatment. Brain Res 654:53-62
7. Grenhoff J, Svensson TH (1993) Prazosin modulates the firing pattern of dopamine neurons in rat ventral tegmental area. Eur J Pharmacol 233:79-84
8. Kleven MS, Koek W (1997) Discriminative stimulus properties of cocaine: enhancement by beta-adrenergic receptor antagonists. Psychopharmacology 131:307-312
9. Kleven MS, Koek W (1998) Discriminative stimulus properties of cocaine: enhancement by monoamine reuptake blockers. J Pharmacol Exp Ther 284:1015-1025
10. Krimmer EC, McGuire MS, Barry HIII (1984) Effects of the training dose on generalization of morphine stimulus to clonidine. Pharmacol Biochem Behav 20:669-673
11. Kuczenski R, Segal DS, Cho AK, Melega W (1995) Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine. J Neurosci 15:1308-17
12. Lal H, Yaden S, Forster MJ (1990) Elevation of blood pressure as the basis for discriminative stimuli produced by methoxamine. Drug Dev Res 20:145-153
13. Maldonado R (1997) Participation of noradrenergic pathways in the expression of opiate withdrawal: biochemical and pharmacological evidence. Neurosci Biobehav Rev 21:91-104
14. McDougle CJ, Black JE, Malison RT, Zimmermann RC, Kosten TR, Heninger GR, Price LH (1994) Noradrenergic dysregulation during discontinuation of cocaine use in addicts. Arch Gen Psychiatry 51:713-719
15. 3 receptor antagonist thioperamide in rats. Eur J Pharmacol 363:93-101
16. Munzar P, Nováková J, Goldberg SR (1998b) Serotonergic modulation of methamphetamine's discriminative stimulus effects in rats. Behav Pharmacol 9:S66
17. Munzar P, Baumann MH, Shoaib M, Goldberg SR (1999) Effects of dopamine and serotonin-releasing agents on methamphetamine discrimination and self-administration in rats. Psychopharmacology 141:287-296
18. National Research Council (1996) Guide for the care and use of laboratory animals. National Academy Press, Washington, D.C.
19. Nutt D, Lalies M, Hudson A (1994) The effects of alpha-2 adrenoceptor antagonists on extracellular dopamine concentrations in rat striatum. In: Briley M, Marien M (eds) Noradrenergic mechanisms in Parkinson's disease. CRC Press, Boca Raton, pp 159-172
20. Pan WHT, Sung J-C, Fuh SMR (1996) Locally application of amphetamine into the ventral tegmental area enhances dopamine release in the nucleus accumbens and the medial prefrontal cortex through noradrenergic neurotransmission. J Pharmacol Exp Ther 278:725-731
21. Pozzi L, Invernizzi R, Cervo L, Vallebuona F, Samanin R (1994) Evidence that extracellular concentrations of dopamine are regulated by noradrenergic neurons in the frontal cortex of rats. J Neurochem 63:195-200
22. Ritz MC, Kuhar MJ (1989) Relationship between self-administration of amphetamine and monoamine receptors in brain: comparison with cocaine. J Pharmacol Exp Ther 248:1010-1017
23. Sanger DJ (1988) Behavioural effects of the alpha-2-adrenoceptor antagonists idazoxan and yohimbine in rats: comparison with amphetamine. Psychopharmacology 96:243-249
24. Sasaki JE, Tatham TA, Barrett JE (1995) The discriminative stimulus effects of methamphetamine in pigeons. Psychopharmacology 120:303-310
25. Scatton B, Zivkovic B, Dedek J (1980) Antidopaminergic properties of yohimbine. J Pharmacol Exp Ther 215:494-499
26. Schindler CW, Zheng JW, Tella SR, Goldberg SR (1992) Pharmacological mechanisms in the cardiovascular effects of methamphetamine in conscious squirrel monkeys. Pharmacol Biochem Behav 42:791-796
27. Snoddy AM, Tessel RE (1983) Nisoxetine and amphetamine share discriminative stimulus properties in mice. Pharmacol Biochem Behav 19:205-210
28. Snoddy AM, Tessel RE (1985) Prazosin: effect on psychomotorstimulant cues and locomotor activity in mice. Eur J Pharmacol 116:221-228
29. Spealman RD (1995) Noradrenergic involvement in the discriminative stimulus effects of cocaine in squirrel monkeys. J Pharmacol Exp Ther 275:53-62
30. Tanda G, Pontieri FE, Frau R, DiChiara G (1997) Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine. Eur J Neurosci 9:2077-2085
31. Tassin J-P (1998) Norepinephrine-dopamine interactions in the prefrontal cortex and the ventral tegmental area: relevance to mental diseases. Adv Pharmacol 42:712-716
32. Tessel RE (1990) Noradrenergic processes in the behavioral actions of psychomotor stimulants. Drug Dev Res 20:359-368
33. Tidey JW, Bergman J (1998) Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs. J Pharmacol Exp Ther 285:1163-1174
34. Veprek P, Batra S, Korecky B, Rakusan K (1991) Isoproterenol induced rat endomyocardial damage in relationship to local capillary geometry. Basic Res Cardiol 86:434-440
35. West WB, Van Groll BJ, Appel JB (1995) Stimulus effects of d-amphetamine II: DA, NE, and 5-HT mechanisms. Pharmacol Biochem Behav 51:69-76
36. Witkin JM, Savtchenko N, Mashkovsky M, Beekman M, Munzar P, Gasior M, Goldberg SR, Ungard JT, Kim J, Shippenberg T, Chefer V (1999) Behavioral, toxic and neurochemical effects of sydnocarb, a novel psychomotor stimulant: comparisons with methamphetamine. J Pharmacol Exp Ther (in press)
37. Wood DM, Lal H, Yaden S, Emmett-Oglesby MW (1985) Oneway generalization of clonidine to the discriminative stim ulus produced by cocaine. Pharmacol Biochem Behav 23:529-533
38. Yasar S, Schindler CW, Thorndike EB, Szelenyi I, Goldberg SR (1993) Evaluation of the stereoisomers of deprenyl for amphetamine-like discriminative stimulus effects in rats. J Pharmacol Exp Ther 265:1-6
39. Yavich L, Lappalainen R, Sirvio J, Haapalinna A, MacDonald E (1997) Alpha-2-adrenergic control of dopamine overflow and metabolism in mouse striatum. Eur J Pharmacol 339:113-119
40. Yui K, Goto K, Ikemoto S, Ishiguro T (1996) Plasma monoamine metabolites and spontaneous recurrence of methamphetamine-induced paranoid-hallucinatory psychosis: relation of noradrenergic activity to the occurrence of flashbacks. Psychiatry Res 63:93-107
41. Yui K, Ishiguro T, Goto K, Ikemoto S (1997) Precipitating factors in spontaneous recurrence of methamphetamine psychosis. Psychopharmacology 134:303-308